TITLE

Effect of Rosiglitazone and Metformin on Insulin Resistance in Patients Infected with Human Immunodeficiency Virus Receiving Highly Active Antiretroviral Therapy Containing Protease Inhibitor: Randomized Prospective Controlled Clinical Trial

AUTHOR(S)
Silic, Anja; Jane�, Andrej; Toma�ic, Janez; Karner, Primo�; Vidmar, Ludvik; Sharma, Prem; Maticic, Mojca
PUB. DATE
December 2007
SOURCE
Croatian Medical Journal;2007, Vol. 48 Issue 6, p791
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
28160471

 

Related Articles

  • Advances in the nutritional handling of patient with AIDS. Luciana, Coppini Z.; Dan, Waitzberg I.; de Lourdes, Teixeira da Silva Maria // Nutrición Clínica;2008, Vol. 11 Issue 1, p35 

    The introduction of highly active antiretroviral therapy (HAART) has reduced morbidity and mortality in patients infected with the human immunodeficiency virus (HIV). However, the treatment with antiretroviral agents - protease inhibitors in particular - has uncovered a syndrome of abnormal fat...

  • Factors Related to Lipodystrophy and Metabolic Alterations in Patients with Human Immunodeficiency Virus Infection Receiving Highly Active Antiretroviral Therapy. Saves, Marianne; Raffi, Francois; Capeau, Jacqueline; Rozenbaum, Willy; Ragnaud, Jean-Marie; Perronne, Christian; Basdevant, Arnaud; Leport, Catherine; Chene, Genevieve // Clinical Infectious Diseases;5/15/2002, Vol. 34 Issue 10, p1396 

    Presents a study which examined the factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Morphologic and metabolic changes associated with protease inhibitor; Clinical evaluation of fat...

  • A Randomized, Placebo-Controlled Trial of Rosiglitazone for HIV-Related Lipoatrophy. Cavalcanti, Rodrigo B.; Raboud, Janet; Shen, Sandy; Kain, Kevin C.; Cheung, Angela; Walmsley, Sharon // Journal of Infectious Diseases;6/15/2007, Vol. 195 Issue 12, p1754 

    Background. Thiazolidinediones such as rosiglitazone may have benefit in ameliorating human immunodeficiency virus (HIV) lipoatrophy. Methods. HIV-positive patients receiving stable, protease inhibitor-containing highly active antiretroviral therapy with HIV lipodystrophy were prospectively...

  • Comparison of Rosiglitazone and Metformin for Treating HIV Lipodystrophy: A Randomized Trial. van Wijk, Jeroen P. H.; de Koning, Eelco J. P.; Cabezas, Manuel Castro; Roodt, Jos op't; Joven, Jorge; Rabelink, Ton J.; Hoepelman, Andy I. // Annals of Internal Medicine;9/6/2005, Vol. 143 Issue 5, p337 

    Background: The use of antiretroviral combination therapy in HIV has been associated with lipodystrophy and cardiovascular risk factors. Objective: To compare the effects of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone and metformin for treating HIV lipodystrophy....

  • Clearance of Hepatitis G viremia in a Human Immunodeficiency Virus--Positive Patient by... Toyoda, Hidenori; Fukuda, Yoshihide; Takamatsu, Junki // Clinical Infectious Diseases;11/1/1999, Vol. 29 Issue 5, p1332 

    Discusses the clearance of hepatitis G viremia in a human immunodeficiency virus (HIV)-positive patient by high-activity antiretroviral therapy (HAART). Diagnosis for a 40-year-old HIV-positive man; Protease inhibitor therapy for the patient; Association of coinfection with HIV with persistent...

  • highly active antiretroviral therapy (HAART):. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p108 

    An encyclopedia entry for "highly active antiretroviral therapy" is presented. This therapy refers to a powerful combination of drugs, which renders human immunodeficiency viruses undetectable in the body of an infected person. This therapy contains one drug that is usually an HIV protease...

  • HAART therapy: Dividing the epidemic? Laurence, Jeffrey // AIDS Patient Care & STDs;Dec97, Vol. 11 Issue 6, p397 

    Editorial. Offers information pertaining to acquired immunodeficiency syndrome (AIDS) and highly active anti-retroviral therapy (HAART). Where HAART became a high point in Toronto, Canada; Effect of HAART; Results of several trials of protease-inhibitor-based anti human immunodeficiency virus...

  • Antiretroviral treatment and malaria protection in HIV-infected Ugandan children.  // Archives of Disease in Childhood;Apr2013, Vol. 98 Issue 4, p257 

    The article focuses on the use of antiretroviral therapies (ARTs) for protection against malaria in Human Immunodeficiency Virus (HIV) infected children of Uganda. It mentions that proteases in HIV and in Plasmodium falciparum have biochemical similarities and for this reason antiretroviral...

  • Reviewing the Cardiovascular Complications of HIV Infection After the Introduction of Highly Active Antiretroviral Therapy. Barbaro, G. // Current Drug Targets - Cardiovascular & Haematological Disorders;Aug2005, Vol. 5 Issue 4, p337 

    Studies published before the introduction of highly active antiretroviral therapy (HAART) have tracked the incidence and course of human immunodeficiency virus (HIV) infection in relation to cardiac disease.The introduction of HAART regimens, by preventing opportunistic infections and reducing...

  • Current Treatment of HIV Infection. Portsmouth, Simon; Stebbing, Justin; Gazzard, Brian // Current Topics in Medicinal Chemistry;Sep2003, Vol. 3 Issue 13, p1458 

    The field of antiretroviral therapy has witnessed remarkable progress during the past 15 years. There are now over a dozen approved therapeutic agents for infection with the human immunodeficiency virus (HIV), a pathogen that once caused nearly uniformly fatal illness. These agents usually...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics